Pfizer, Moderna shares plummet after Biden administration backs a COVID-19 vaccine patent waiver

Pfizer, Moderna shares plummet after Biden administration backs a COVID-19 vaccine patent waiver

The United States will advocate for waiving COVID-19 vaccine patent protections in discussions with the World Trade Organization, U.S. Trade Representative Katherine Tai announced Wednesday. The Biden administration "believes strongly in intellectual property protections," Tai said in a statement, but the White House will back the waiver given the "extraordinary circumstances of the COVID-19 pandemic."

View Full Post

More great content like this @ Business & Economy Front Page or you can Request Invite

Leave a comment